In head and neck cancer, loss of tumor protein 53 leads to adrenergic transdifferentiation of tumor-associated sensory nerves through loss of the microRNA miR-34a, and tumor growth is suppressed by sensory denervation [130]. The gene discussed is TP53; the disease is neoplasm.